3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Alembic Pharmaceuticals Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Dose Crossover Comparative Bioavailability Study of Bupropion Hcl MR Tablet 300mg Bupropion HCl MR tablets 300mg - Bioequivalence | Phase 1 | Completed | Alembic Pharmaceuticals Ltd. | 34 | 2020-01-18 | 2022-05-09 |
| Comparative Bioavailability Study of Lamotrigine ER Tablets USP 50 mg Lamotrigine ER tablet 50mg - Bioequivalence | Phase 1 | Completed | Alembic Pharmaceuticals Ltd. | 22 | 2018-01-10 | 2021-12-07 |
| Oral Bio-equivalence Study Fingolimod 0.5 mg capsules- Test drug - Bioequivalence, Safety | Phase 1 | Completed | Alembic Pharmaceuticals Ltd. | 26 | 2015-10-29 | 2021-12-21 |
Bupropion (1) · Fingolimod Hydrochloride (1) · Lamotrigine (1)
Canada (3)
Eric Sicard, MD (2) · Eric Sicard, M.D. (1)